---
schema_version: "secwatch.filing_event.v1"
accession: "0001841387-26-000007"
form_type: "8-K"
ticker: "CADL"
cik: "0001841387"
company_name: "Candel Therapeutics, Inc."
filed_at: "2026-06-16T20:23:50+00:00"
generated_at: "2026-06-16T20:25:23.306687+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Candel Therapeutics formalizes CFO employment agreement with $468,600 salary, 40% target bonus

## Summary
- CFO Charles Schoch's new agreement sets base salary at $468,600 and target annual bonus at 40% of base.
- Severance on termination without cause or for good reason: 9 months base salary plus target bonus.
- Time-based equity awards fully accelerate if termination occurs within 1 month before or 12 months after change in control.
- Agreement includes standard confidentiality, non-compete, and non-solicitation covenants.

## SEC filing metadata
- accession: 0001841387-26-000007
- form_type: 8-K
- ticker: CADL
- cik: 0001841387
- company_name: Candel Therapeutics, Inc.
- filed_at: 2026-06-16T20:23:50+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841387/000184138726000007/0001841387-26-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841387/000184138726000007/cadl-20260612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001841387-26-000007
- JSON: https://secwatch.observer/filing/0001841387-26-000007.json
- Plain text: https://secwatch.observer/filing/0001841387-26-000007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.